Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Cerevel Therapeutics Holdings, Inc. (CERE)  
$44.63 0.00 (0.00%) as of 4:30 Tue 7/30


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 156,320,000
Market Cap: 6.98(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $20.26 - $44.96
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  402
Guru Rank Value     : 5.7
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Cerevel Therapeutics Holdings is a clinical-stage biopharmaceutical company. Co.'s programs: Emraclidine is a positive allosteric modulator (PAM), that selectively targets the muscarinic acetylcholine 4 receptor subtype; Darigabat, which is a PAM that selectively targets the alpha-2/3/5 subunits of the GABAA receptor; Tavapadon, which is a selective dopamine D1/D5 receptor partial agonist that it is developing for the treatment of early- and late-stage Parkinson's disease; and CVL-871, which is a selective dopamine D1/D5 receptor partial agonist specifically designed to achieve a level of partial agonism.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 17,316,964 17,422,701
Total Buy Value $0 $0 $394,999,948 $397,510,553
Total People Bought 0 0 4 6
Total Buy Transactions 0 0 4 6
Total Shares Sold 25,000 175,000 584,132 1,036,027
Total Sell Value $1,029,535 $7,281,820 $21,771,632 $34,841,114
Total People Sold 1 1 8 8
Total Sell Transactions 1 4 26 38
End Date 2024-06-27 2024-03-26 2023-09-26 2022-09-26

   
Records found: 181
  Page 7 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Edelman Joseph Director   –       •      –    2021-08-25 4 B $28.57 $1,753,827 I/I 61,387 5,018,680 2.1     -
   Edelman Joseph Director   –       •      –    2021-08-24 4 B $27.73 $1,934,473 I/I 69,761 4,957,293 2.1     -
   Edelman Joseph Director   –       •      –    2021-08-23 4 B $25.78 $1,145,586 I/I 44,437 4,887,532 2.1     -
   Edelman Joseph Director   –       •      –    2021-07-07 4 B $25.00 $5,000,000 I/I 200,000 4,843,095 2.1     -
   Greene Gabrielle E Director   –       •      –    2021-06-24 4 OE $0.00 $0 D/D 14,270 49,624     -
   Greene Gabrielle E Director   –       •      –    2021-06-17 4 B $13.06 $275,357 D/D 21,084 35,354 2.39     -
   Mishan Orly Chief Business Officer   •       –      –    2021-01-26 4 OE $3.50 $134,575 D/D 38,450 38,450     -
   Riedel Norbert G Director   –       •      –    2021-01-04 4 OE $0.00 $0 D/D 14,270 28,540     -
   Koppel Adam Director   –       •       •   2020-11-09 4 B $10.30 $3,422,618 I/I 332,293 60,632,356 2.25     -
   Bain Capital Partners Xii, Llc 10% Owner   –       –       •   2020-11-09 4 B $10.30 $3,422,618 I/I 332,293 60,632,356 1.5     -
   Gordon Christopher R Director   –       •       •   2020-11-09 4 B $10.30 $3,422,618 I/I 332,293 60,632,356 2.25     -
   Dipietro Kenneth Chief Human Resources OfficerO   •       –      –    2020-10-27 3 IO $0.00 $0 D/D 0 14,270     -
   Dekkers Marijn E Director   –       •      –    2020-10-27 3 IO $0.00 $0 D/D 0 28,540     -
   Riedel Norbert G Director   –       •      –    2020-10-27 3 IO $0.00 $0 D/D 0 14,270     -
   Greene Gabrielle E Director   –       •      –    2020-10-27 3 IO $0.00 $0 D/D 0 14,270     -
   Bain Capital Partners Xii, Llc 10% Owner   –       –       •   2020-10-27 3 IO $0.00 $0 I/I 0 50,300,063     -
   Pfizer Inc 10% Owner   –       –       •   2020-10-27 3 IO $0.00 $0 D/D 0 26,149,211     -
   Gordon Christopher R Director   –       •      –    2020-10-27 3 IO $0.00 $0 I/I 0 338,120     -
   Koppel Adam Director   –       •      –    2020-10-27 3 IO $0.00 $0 I/I 0 338,120     -
   Gordon Christopher R Director   –       •       •   2020-10-27 4 B $10.00 $100,000,000 I/I 10,000,000 60,300,063 2.25     -
   Gordon Christopher R Director   –       •       •   2020-10-27 4 A $0.00 $0 I/I 49,961,943 50,300,063     -
   Edelman Joseph Director   –       •      –    2020-10-27 4 B $10.00 $30,000,000 I/I 3,000,000 3,157,295 2.1     -
   Koppel Adam Director   –       •       •   2020-10-27 4 B $10.00 $100,000,000 I/I 10,000,000 60,300,063 2.25     -
   Koppel Adam Director   –       •       •   2020-10-27 4 A $0.00 $0 I/I 49,961,943 50,300,063     -
   Bain Capital Partners Xii, Llc 10% Owner   –       –       •   2020-10-27 4 B $10.00 $100,000,000 I/I 10,000,000 60,300,063 1.5     -
  181 Records found
  1  2  3  4  5  6  7  8   
  Page 7 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us